long intergenic non-protein coding RNA 1986Genealiases: []
Q-omics provides the consensus-scored LINC01986 profile across patient tissues and cancer cell-line models. LINC01986 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in BRCA. Among the 18 cancer types available for tumor–normal comparison, LINC01986 is differentially expressed in 1, with the highest sampling consensus in LIHC. Additionally, LINC01986 RNA expression shows 2,964 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight BRCA, LIHC, and COAD as cancer lineages where LINC01986 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01986 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01986 survival associations across molecular data types. LINC01986 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01986 RNA expression–survival associations across cancer types. High LINC01986 expression shows unfavorable associations in BRCA, UCS, BLCA, HNSC, KICH and READ. The BRCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BRCA as the clearest survival context for LINC01986 RNA expression.
This table summarizes LINC01986 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01986. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01986 shows lower tumor expression in LIHC. The LIHC box plot shows higher LINC01986 RNA expression in normal versus tumor tissue (log2 FC = −0.020, t-test p = .011).
This table shows molecular features associated with LINC01986 in patient tissues and cancer cell lines. In patient samples, LINC01986 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
